Profile | GDS2987 / Hs.491466-S |
Title | Comparison of Rho kinase inhibitor and atorvastatin effects on primary cell lines |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM214810 | HMVEC_vehicle_rep1 | 43.5 | 69 |
GSM215244 | HMVEC_vehicle_rep2 | 91.5 | 75 |
GSM215253 | HMVEC_vehicle_rep3 | 53 | 71 |
GSM215254 | HMVEC_atorvastatin_rep1 | 53.3 | 69 |
GSM215282 | HMVEC_atorvastatin_rep3 | 51.6 | 68 |
GSM215344 | HMVEC_atorvastatin_rep2 | 77.4 | 73 |
GSM215283 | HMVEC_atorvastatin_mevalonate_rep1 | 105.4 | 76 |
GSM215284 | HMVEC_atorvastatin_mevalonate_rep2 | 94 | 75 |
GSM215293 | HMVEC_atorvastatin_mevalonate_rep3 | 119.5 | 77 |
GSM215294 | HMVEC_SLx2119_rep1 | 51 | 71 |
GSM215295 | HMVEC_SLx2119_rep2 | 40.9 | 60 |
GSM215296 | HMVEC_SLx2119_rep3 | 10.3 | 17 |
GSM215297 | PASMC_vehicle_rep1 | 14.3 | 22 |
GSM215298 | PASMC_vehicle_rep2 | ||
GSM215310 | PASMC_vehicle_rep3 | 7.4 | 12 |
GSM215311 | PASMC_atorvastatin_rep1 | ||
GSM215312 | PASMC_atorvastatin_rep2 | ||
GSM215313 | PASMC_atorvastatin_rep3 | ||
GSM215324 | PASMC_atorvastatin_mevalonate_rep1 | ||
GSM215325 | PASMC_atorvastatin_mevalonate_rep2 | 6.5 | 13 |
GSM215326 | PASMC_atorvastatin_mevalonate_rep3 | ||
GSM215327 | PASMC_SLx2119_rep1 | 8.4 | 15 |
GSM215328 | PASMC_SLx2119_rep2 | 4.3 | 8 |
GSM215329 | PASMC_SLx2119_rep3 | 4.9 | 10 |
GSM215330 | Fibroblasts_vehicle_rep1 | ||
GSM215331 | Fibroblasts_vehicle_rep2 | 9.4 | 26 |
GSM215332 | Fibroblasts_vehicle_rep3 | ||
GSM215333 | Fibroblasts_atorvastatin_rep1 | 12.5 | 32 |
GSM215334 | Fibroblasts_atorvastatin_rep2 | 2 | 6 |
GSM215335 | Fibroblasts_atorvastatin_rep3 | 3.9 | 10 |
GSM215336 | Fibroblasts_atorvastatin_mevalonate_rep1 | 7.1 | 24 |
GSM215337 | Fibroblasts_atorvastatin_mevalonate_rep2 | 10.4 | 32 |
GSM215338 | Fibroblasts_atorvastatin_mevalonate_rep3 | 9.3 | 26 |
GSM215339 | Fibroblasts_SLx2119_rep1 | 4 | 12 |
GSM215340 | Fibroblasts_SLx2119_rep2 | 3.4 | 10 |
GSM215341 | Fibroblasts_SLx2119_rep3 | 1.7 | 5 |